Glivec dissected: Must-read (long) feature in the Caravan delving into the history, background and repercussions on the Novartis Supreme Court patent judgment and the future of IP laws in India and globally [Caravan]

Public interest injections: Serial PIL lawyer ML Sharma filed in the SC yesterday seeking cancellation of generic drugs maker Ranbaxy’s manufacturing license on the grounds that it fudged data and sold adulterated products in the US [ET]

Taskmaster SEBI: SEBI has taken action against 105 companies that have flouted its minimum public shareholding norms and have missed the 3 June deadline to dilute promoter stakes. It has suspended 33 companies [Hindu BL/order]

Free speech SLAPPed: The Centre for Internet & Society (CIS) discusses the increasing incidence of SLAPP suits (Strategic Lawsuits Against Public Participation) and how they target free speech by holding a gun to the head of commentators and authors of academic opinion [CIS-India]

NHPC deal auction: 15 law firms including Luthra & Luthra and AZB & Partners will bid this month for a role on the divestment of 11.36 per cent stake in the National Hydropower Corporation for over Rs 2,200 crore [PTI]

CCI penance delays: The Competition Commission of India (CCI) is yet to realise a majority of the Rs 8,000 crore it has imposed in penalties since its inception, since all defaulters have appealed before the judiciary [SME Times]

Release thy neighbour: Supreme Court justice AK Ganguly is in Pakistan with SC lawyers Colin Gonsalves, Prashant Bhushan, Mukul SInha and Nijhari Sinha to attend an Indo-Pak conference on judicial activism, PIL, and human rights. The delegation will invite the Chief Justice of Pakistan to India to discuss the release of Pakistan’s prisoners in Indian jails [Pakistan Today]

Fat packets: Clifford Chance hikes newly-qualified associate pay up to £76,200 (Rs 67 lakh) with maximum bonus [The Lawyer]